BELLEVUE, Wash.--(BUSINESS WIRE)--EMulate Therapeutics, Inc. (EMulate) announced today the publication of its peer-reviewed clinical trial using EMulate’s technology for the treatment of glioblastoma ...
BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation in vitro models, today announced the launch of the Emulate Chip-A1™ Accessible Chip through an early access program.
The organ-on-a-chip developer Emulate has raised $82 million to boost its offerings aimed at replicating human biology through easier-to-manage in vitro cellular models. Used in past drug development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results